top of page
![News Headings.jpg](https://static.wixstatic.com/media/22ea40_5124864fef57437b8c782287bc11c9c1~mv2.jpg/v1/fill/w_980,h_396,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/22ea40_5124864fef57437b8c782287bc11c9c1~mv2.jpg)
NEWS & BLOGS
Blog: Blog2
![](https://static.wixstatic.com/media/22ea40_9a17cf74882a4dd6bcfd4e7b83f4b973~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_9a17cf74882a4dd6bcfd4e7b83f4b973~mv2.webp)
![[FDA Regulatory] De Novo Summaries](https://static.wixstatic.com/media/22ea40_9a17cf74882a4dd6bcfd4e7b83f4b973~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_9a17cf74882a4dd6bcfd4e7b83f4b973~mv2.webp)
Provision Consulting Group
Jun 26, 20232 min read
[FDA Regulatory] De Novo Summaries
In the FDA, medical devices are classified into three categories (Class I, II, and III) based on their level of risk. A 510(k) pre-market...
16
![](https://static.wixstatic.com/media/22ea40_e7823c074c8844e3b177345512ad991c~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_e7823c074c8844e3b177345512ad991c~mv2.webp)
![[FDA News] Starting October 1, 2023, all 510(k) submissions must be submitted through eSTAR](https://static.wixstatic.com/media/22ea40_e7823c074c8844e3b177345512ad991c~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_e7823c074c8844e3b177345512ad991c~mv2.webp)
Provision Consulting Group
Jun 14, 20232 min read
[FDA News] Starting October 1, 2023, all 510(k) submissions must be submitted through eSTAR
On June 9, 2023, the FDA announced that through eSTAR (The electronic Submission Template and Resource), it is now possible to submit...
35
![](https://static.wixstatic.com/media/22ea40_74b33632466948ebbe9aabff1fabfd9e~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_74b33632466948ebbe9aabff1fabfd9e~mv2.webp)
![[FDA News] Regulatory Education for Industry (REdI) Annual Conference 2023](https://static.wixstatic.com/media/22ea40_74b33632466948ebbe9aabff1fabfd9e~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_74b33632466948ebbe9aabff1fabfd9e~mv2.webp)
Provision Consulting Group
Jun 2, 20231 min read
[FDA News] Regulatory Education for Industry (REdI) Annual Conference 2023
The FDA will be hosting the Regulatory Education for Industry (REdI) Annual Conference 2023 free of charge. Date: June 5(Mon) – June...
21
![](https://static.wixstatic.com/media/22ea40_13170b7aff0e4c798977a3604666f756~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_13170b7aff0e4c798977a3604666f756~mv2.webp)
![The difference between FDA Registered, FDA Cleared, and FDA Approved](https://static.wixstatic.com/media/22ea40_13170b7aff0e4c798977a3604666f756~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_13170b7aff0e4c798977a3604666f756~mv2.webp)
Provision Consulting Group
May 31, 20232 min read
The difference between FDA Registered, FDA Cleared, and FDA Approved
When examining advertisements for medical devices, it is common to come across the phrase "FDA approved" to enhance the credibility and...
41
![](https://static.wixstatic.com/media/22ea40_8152814977e24aa6ba6a652204e4e3ea~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/22ea40_8152814977e24aa6ba6a652204e4e3ea~mv2.webp)
![How Should Cosmetics Companies Prepare for MoCRA?](https://static.wixstatic.com/media/22ea40_8152814977e24aa6ba6a652204e4e3ea~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/22ea40_8152814977e24aa6ba6a652204e4e3ea~mv2.webp)
Provision Consulting Group
May 24, 20232 min read
How Should Cosmetics Companies Prepare for MoCRA?
Updated on 9/7/23. On December 29, 2022, the FDA enacted "The Modernization of Cosmetics Regulation Act (MOCRA)." The critical of the...
271
![](https://static.wixstatic.com/media/7ffba2_8c5d9e205c784fbcb8a3e71a0a12c577~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/7ffba2_8c5d9e205c784fbcb8a3e71a0a12c577~mv2.webp)
![FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene](https://static.wixstatic.com/media/7ffba2_8c5d9e205c784fbcb8a3e71a0a12c577~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/7ffba2_8c5d9e205c784fbcb8a3e71a0a12c577~mv2.webp)
Provision Consulting Group
Apr 26, 20231 min read
FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
The FDA approved a treatment for individuals who have amyotrophic lateral sclerosis (ALS) and carry a specific genetic mutation known as...
23
![](https://static.wixstatic.com/media/7ffba2_f9740ca6a04f4582b5f7c910439e69edf000.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/7ffba2_f9740ca6a04f4582b5f7c910439e69edf000.webp)
![Modernization of Cosmetics Regulation Act of 2022 (MOCRA)](https://static.wixstatic.com/media/7ffba2_f9740ca6a04f4582b5f7c910439e69edf000.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/7ffba2_f9740ca6a04f4582b5f7c910439e69edf000.webp)
Provision Consulting Group
Apr 19, 20232 min read
Modernization of Cosmetics Regulation Act of 2022 (MOCRA)
On March 27, 2023, the FDA update announced that has stopped accepting submissions to the Voluntary Cosmetic Registration Program(VCRP)...
78
![](https://static.wixstatic.com/media/7ffba2_3f0d4e9206cd4f7b9678fb390a3ded41f000.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/7ffba2_3f0d4e9206cd4f7b9678fb390a3ded41f000.webp)
![[FDA News] Public Meeting: Good Manufacturing Practices for Cosmetic Products](https://static.wixstatic.com/media/7ffba2_3f0d4e9206cd4f7b9678fb390a3ded41f000.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/7ffba2_3f0d4e9206cd4f7b9678fb390a3ded41f000.webp)
Provision Consulting Group
Apr 19, 20231 min read
[FDA News] Public Meeting: Good Manufacturing Practices for Cosmetic Products
FDA will have a public meeting for good manufacturing practices for cosmetic products. Please save the date: The U.S. Food and Drug...
32
![](https://static.wixstatic.com/media/7ffba2_c7e318bc62db43a38c5e62da6ed4ba5b~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/7ffba2_c7e318bc62db43a38c5e62da6ed4ba5b~mv2.webp)
![POSCO - Venture Companies Global Bio Forum 2023 from Provision Consulting Group](https://static.wixstatic.com/media/7ffba2_c7e318bc62db43a38c5e62da6ed4ba5b~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/7ffba2_c7e318bc62db43a38c5e62da6ed4ba5b~mv2.webp)
Provision Consulting Group
Apr 17, 20231 min read
POSCO - Venture Companies Global Bio Forum 2023 from Provision Consulting Group
Mr. Kwon from Provision Consulting Group traveled to South Korea and presented a topic related to the regulatory perspective in the US...
30
![](https://static.wixstatic.com/media/7ffba2_1fa964a7adb64706aca571d2011df970~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/7ffba2_1fa964a7adb64706aca571d2011df970~mv2.webp)
![Provision Consulting Group traveled for FDA GMP/QMS Mock audit in South Korea](https://static.wixstatic.com/media/7ffba2_1fa964a7adb64706aca571d2011df970~mv2.jpg/v1/fill/w_454,h_256,fp_0.50_0.50,q_90,enc_auto/7ffba2_1fa964a7adb64706aca571d2011df970~mv2.webp)
Provision Consulting Group
Apr 13, 20231 min read
Provision Consulting Group traveled for FDA GMP/QMS Mock audit in South Korea
In March, 2023, Mr. Kwon, one of the Co-CEOs of Provision Consulting Group, traveled to South Korea to provide consulting services and...
55
bottom of page